SWOT Analysis for Arcturus Therapeutics Holdings Inc

Significant (over 30%) distance from 52 week high
PEG lower than Industry PEG
Stock with Low PE (PE < = 10)

Negative Breakdown First Support (LTP < S1)
Stocks with Quarter Change % less than Industry
Bearish Stocks - Stocks with Medium to Low Trendlyne Momentum Score
Low DVM Stocks - Stocks to Exercise Caution On
Lowest Momentum Scores (Technical Scores)
Stocks with Expensive Valuations according to the Trendlyne Valuation Score
Low durability companies
Weak Stocks (DVM)
Poor cash generated from core business - Declining Cash Flow from Operations for last 2 years
Highest fall from 52 Week High
Top Losers
Negative Breakdown First Support (LTP < S1)
Degrowth in Quarterly Revenue and Profit in Recent Results(YoY)
Low Piotroski Score : Companies with weak financials
Declining Net Cash Flow : Companies not able to generate net cash
Annual net profit declining for last 2 years
Weak performer : Stock lost more than 20% in 1 month
Weak Momentum: Price below Short, Medium and Long Term Averages
Declining Revenue every quarter for the past 2 quarters
RSI indicating price weakness
Top Losers
Stocks Underperforming their Industry Price Change in the Quarter